Clinical Trial

The Influence of Treatment Format on Schema Therapy for Borderline Personality Disorder

Study acronym: IST-IGST
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to compare etc. in patients with borderline personality disorder pure individual schema therapy to combined individual-group schema therapy. The main questions it aims to answer are: * is there a difference in effectiveness? * is there a difference in (early) treatment dropout? Participants will receive either * individual schema therapy or * combined individual-group schema therapy. Researchers will compare individual to combined individual-group schema therapy see if there is a difference in effects and/or a difference in dropout from treatment.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-08-03; most recent amendment 2026-04-29.
Status change: Not Yet Recruiting → Enrolling by Invitation 2023-11-29
Trial Details
NCT Number NCT05986552
Lead Sponsor University of Amsterdam
Collaborators: Academic Center for Trauma and Personality, Arkin Mental Health Care, Ggz Oost Brabant
Conditions Borderline Personality Disorder
Enrollment 132 participants
Start Date 2023-11-10
Primary Completion 2030-08-30 (estimated)
Study Completion 2030-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-06